498 related articles for article (PubMed ID: 27262844)
1. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
[TBL] [Abstract][Full Text] [Related]
2. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
[TBL] [Abstract][Full Text] [Related]
4. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
[TBL] [Abstract][Full Text] [Related]
5. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.
Zachou K; Azariadis K; Lytvyak E; Snijders RJALM; Takahashi A; Gatselis NK; Robles M; Andrade RJ; Schramm C; Lohse AW; Tanaka A; Drenth JPH; Montano-Loza AJ; Dalekos GN;
JHEP Rep; 2023 Aug; 5(8):100778. PubMed ID: 37456672
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
[TBL] [Abstract][Full Text] [Related]
7. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.
Kado A; Tsutsumi T; Yotsuyanagi H; Ikeuchi K; Okushin K; Moriya K; Koike K; Fujishiro M
J Gastroenterol; 2023 Dec; 58(12):1237-1251. PubMed ID: 37707595
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
11. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
Marengo A; Jouness RI; Bugianesi E
Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
[TBL] [Abstract][Full Text] [Related]
14. Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes.
Strzepka J; Schwartz BA; Ritz EM; Aloman C; Reau N
J Clin Gastroenterol; 2024 Jan; 58(1):91-97. PubMed ID: 36729430
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
Danielsson Borssén Å; Marschall HU; Bergquist A; Rorsman F; Weiland O; Kechagias S; Nyhlin N; Verbaan H; Nilsson E; Werner M
Scand J Gastroenterol; 2017 Sep; 52(9):1022-1028. PubMed ID: 28562110
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
18. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
[TBL] [Abstract][Full Text] [Related]
19. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.
van den Brand FF; van der Veen KS; de Boer YS; van Gerven NM; Lissenberg-Witte BI; Beuers U; van Erpecum KJ; van Buuren HR; den Ouden JW; Brouwer JT; Vrolijk JM; Verdonk RC; van Hoek B; Koek GH; Drenth JPH; Guichelaar MMJ; Mulder CJJ; Bloemena E; van Nieuwkerk CMJ; Bouma G;
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):940-947.e2. PubMed ID: 30291909
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
Yatsuji S; Hashimoto E; Kaneda H; Taniai M; Tokushige K; Shiratori K
J Gastroenterol; 2005 Dec; 40(12):1130-8. PubMed ID: 16378177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
